Nargiza Nurillaeva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nargiza Nurillaeva has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Munisakhon Makhkamova
Tashkent Medical Academy
5 shared publications - Muborakkhon Zokirova
Republican Specialized Scientific and Practical Medical Center of Hematology, Department of Internal Diseases in Family Medicine №1 and Fundamentals of Preventive Medicine, Tashkent State Medical University, Tashkent 100106, Uzbekistan
3 shared publications - Nargiza A. Khasanova
Department of Internal Diseases in Family Medicine №1 and Fundamentals of Preventive Medicine, Tashkent State Medical University, Tashkent, Uzbekistan, Uzbekistan
3 shared publications - Abror Abdusamatov
Toshkent tibbiyot akademiyasi
2 shared publications - Jakhongir Khaydarov
Department of Internal Diseases in Family Medicine №1 and Fundamentals of Preventive Medicine, Tashkent State Medical University, Tashkent 100109, Uzbekistan
2 shared publications - Kayumov Abdurakhman
Clinical Affairs at the Republican Specialized Scientific and Practical Medical Center of Hematology, Tashkent 100109, Uzbekistan
2 shared publications
Latest Publications
- 2 September 2026
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 40 (10)
Design a Novel Recyclable Fe 3 O 4 @SiO 2 ‐TGDM@Ni MICOF Electrode for CO 2 Trap, Electrolyte, and Catalyst for Electro‐Carboxylation Reaction
The design and development of high‐performance electrocatalytic systems featuring multiple functionalities, excellent recyclability, and reusability constitute a vital and essential advancement in the field of green chemistry. Such innovative approaches significantly mitigate environmental impacts by substantially reducing the discharge of toxic and hazardous pollutants into ecosystems, while concurrently lowering the operational and production costs associated with chemical processes. In alignment with this principle, a novel magnetic electrode based on Fe 3 O 4 @SiO 2 ‐TGDM@Ni was strategically designed and developed. Within this core‐shell architecture, the Fe 3 O 4 @SiO 2 component imparts strong magnetic properties that facilitate straightforward recovery and repeated use of the electrode through simple magnetic separation. The triaminoguanidine dimethoxybenzene (TGDM) layer simultaneously functions as an electrolyte mediator/support and a co‐catalytic promoter, enhancing overall system efficiency. Meanwhile, the Ni NPs serve as the primary electrocatalyst, and thanks to the integrated magnetic recoverability, the entire electrode can be easily retrieved, reused, and assessed for minimal metal leaching. The practical performance of this multifunctional electrode was rigorously evaluated in the electrocarboxylation reaction. The electrochemical synthesis of 2‐phenylpropanoic acid derivatives 3(a–l) was performed under remarkably mild conditions (room temperature, iPrOH) using a constant current of 7 mA for just 1 h. These optimized conditions afforded the products in excellent isolated yields between 90% and 97%. Impressively, it maintained robust catalytic activity and structural integrity across up to 10 consecutive recycling cycles with negligible performance degradation. The core‐shell structured Fe 3 O 4 @SiO 2 ‐TGDM@Ni material underwent comprehensive characterization using a wide array of techniques, including SEM, EDS, TEM, FT‐IR, BET, TGA, VSM, XPS, CV, ICP‐OES and mass spectrometry. Similarly, the resulting 2‐phenylpropanoic acids 3(a‐l) were fully identified and confirmed through melting point determination, 1 H NMR, 13 C NMR spectroscopy, and elemental analysis (CHN).
- 2 September 2026
- Published by Wiley in Applied Organometallic Chemistry
- Vol. 40 (10)
Design a Novel Recyclable Fe 3 O 4 @SiO 2 ‐TGDM@Ni MICOF Electrode for CO 2 Trap, Electrolyte, and Catalyst for Electro‐Carboxylation Reaction
The design and development of high‐performance electrocatalytic systems featuring multiple functionalities, excellent recyclability, and reusability constitute a vital and essential advancement in the field of green chemistry. Such innovative approaches significantly mitigate environmental impacts by substantially reducing the discharge of toxic and hazardous pollutants into ecosystems, while concurrently lowering the operational and production costs associated with chemical processes. In alignment with this principle, a novel magnetic electrode based on Fe 3 O 4 @SiO 2 ‐TGDM@Ni was strategically designed and developed. Within this core‐shell architecture, the Fe 3 O 4 @SiO 2 component imparts strong magnetic properties that facilitate straightforward recovery and repeated use of the electrode through simple magnetic separation. The triaminoguanidine dimethoxybenzene (TGDM) layer simultaneously functions as an electrolyte mediator/support and a co‐catalytic promoter, enhancing overall system efficiency. Meanwhile, the Ni NPs serve as the primary electrocatalyst, and thanks to the integrated magnetic recoverability, the entire electrode can be easily retrieved, reused, and assessed for minimal metal leaching. The practical performance of this multifunctional electrode was rigorously evaluated in the electrocarboxylation reaction. The electrochemical synthesis of 2‐phenylpropanoic acid derivatives 3(a–l) was performed under remarkably mild conditions (room temperature, iPrOH) using a constant current of 7 mA for just 1 h. These optimized conditions afforded the products in excellent isolated yields between 90% and 97%. Impressively, it maintained robust catalytic activity and structural integrity across up to 10 consecutive recycling cycles with negligible performance degradation. The core‐shell structured Fe 3 O 4 @SiO 2 ‐TGDM@Ni material underwent comprehensive characterization using a wide array of techniques, including SEM, EDS, TEM, FT‐IR, BET, TGA, VSM, XPS, CV, ICP‐OES and mass spectrometry. Similarly, the resulting 2‐phenylpropanoic acids 3(a‐l) were fully identified and confirmed through melting point determination, 1 H NMR, 13 C NMR spectroscopy, and elemental analysis (CHN).
- Open Access
- 28 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 1929
An Integrated Model of Cardiotoxicity: Interaction of Age, Sex, and Genetic Polymorphisms in Patients with Acute Leukemia
Background: Cardiotoxic complications represent a major challenge in patients receiving anticancer therapy and may be influenced by interactions among demographic and genetic factors contributing to structural, functional, and electrophysiological myocardial abnormalities. This study aimed to evaluate the effects of age, sex, and genetic polymorphisms on the development of cardiotoxic complications in patients with acute leukemia. Methods: A total of 89 patients aged 18–78 years underwent electrocardiography, echocardiography, and molecular genetic analyses of polymorphisms in GPX4, SOD2, COL1A1, CAT, EDN1, and COMT. Results: Left ventricular hypertrophy (LVH) was detected in 58.4% of patients, reduced left ventricular ejection fraction (LVEF < 50%) in 23.6%, arrhythmias in 46.1%, and ischemic myocardial changes in 28.1%. Older age was significantly associated with LVH, reduced LVEF, and ischemic myocardial changes (all p < 0.05). Sex-specific differences showed a higher prevalence of rhythm disturbances in women and ischemic myocardial changes in men than in women. Individual genetic polymorphisms were significantly associated with specific cardiac phenotypes. Furthermore, combined genetic risk, defined as the presence of two or more unfavorable alleles, was significantly associated with higher rates of LVH, arrhythmias, and impaired myocardial contractility. Multivariate logistic regression identified COMT Val158Met, COL1A1 C1997A, SOD2 C14510A, and EDN1 Lys198Asn as independent genetic predictors of cardiotoxic complications. Conclusions: These findings support a polygenic model of cardiotoxicity and highlight the potential value of integrating demographic and genetic factors for personalized cardiovascular risk stratification, early detection, and prevention of treatment-related cardiac complications.
- 28 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 1929
Open AccessAn Integrated Model of Cardiotoxicity: Interaction of Age, Sex, and Genetic Polymorphisms in Patients with Acute Leukemia
Background: Cardiotoxic complications represent a major challenge in patients receiving anticancer therapy and may be influenced by interactions among demographic and genetic factors contributing to structural, functional, and electrophysiological myocardial abnormalities. This study aimed to evaluate the effects of age, sex, and genetic polymorphisms on the development of cardiotoxic complications in patients with acute leukemia. Methods: A total of 89 patients aged 18–78 years underwent electrocardiography, echocardiography, and molecular genetic analyses of polymorphisms in GPX4, SOD2, COL1A1, CAT, EDN1, and COMT. Results: Left ventricular hypertrophy (LVH) was detected in 58.4% of patients, reduced left ventricular ejection fraction (LVEF < 50%) in 23.6%, arrhythmias in 46.1%, and ischemic myocardial changes in 28.1%. Older age was significantly associated with LVH, reduced LVEF, and ischemic myocardial changes (all p < 0.05). Sex-specific differences showed a higher prevalence of rhythm disturbances in women and ischemic myocardial changes in men than in women. Individual genetic polymorphisms were significantly associated with specific cardiac phenotypes. Furthermore, combined genetic risk, defined as the presence of two or more unfavorable alleles, was significantly associated with higher rates of LVH, arrhythmias, and impaired myocardial contractility. Multivariate logistic regression identified COMT Val158Met, COL1A1 C1997A, SOD2 C14510A, and EDN1 Lys198Asn as independent genetic predictors of cardiotoxic complications. Conclusions: These findings support a polygenic model of cardiotoxicity and highlight the potential value of integrating demographic and genetic factors for personalized cardiovascular risk stratification, early detection, and prevention of treatment-related cardiac complications.
- Open Access
- 27 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 1927
Asymmetric Dimethylarginine as an Integrative Biomarker of Endothelial, Cardiometabolic and Hepatic Dysfunction in Stable Coronary Artery Disease
Background: Coronary artery disease (CAD) frequently coexists with cardiometabolic and hepatic dysfunction, yet accessible biomarkers capturing this convergence remain limited. Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, has been proposed as an integrative marker of endothelial and metabolic impairment. This study aimed to evaluate the diagnostic value of ADMA as a unified biomarker of endothelial dysfunction (ED), cardiometabolic burden, and metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with stable CAD. Methods: In this cross-sectional study, 298 patients with stable CAD (functional class I–II) were enrolled at two centers in Tashkent, Uzbekistan. Serum ADMA was measured by ELISA; endothelial function was assessed by flow-mediated dilation (FMD). Associations between ADMA, metabolic indices, MASLD, and CAD severity were analyzed. Results: MASLD was present in 48.3% of CAD patients and metabolic syndrome (MetS) in 62.4%. Patients with MASLD had more severe angina, reduced exercise tolerance, and greater ischemic burden than those without. ADMA correlated positively with BMI, waist circumference, TyG index, and TG/HDL-C ratio (all p < 0.001), with the TyG index showing the strongest predictive value for elevated ADMA (AUC 0.76). A dose–response relationship linked rising ADMA to worsening FMD; concentrations >160 ng/mL conferred markedly increased odds of overt ED (OR 114.8, 95% CI 6.8–1935.0) and were disproportionately prevalent in patients with MASLD (93.1% vs. 61.0%, p < 0.001). Conclusions: ADMA is markedly elevated in stable CAD and closely tracks endothelial, metabolic, and hepatic dysfunction. These cross-sectional associations position ADMA as a promising, hypothesis-generating integrative biomarker; prospective longitudinal studies are needed before its use for risk stratification in primary and cardiovascular care can be recommended.
- 27 August 2026
- Published by MDPI AG in Biomedicines
- Vol. 14 (9) , 1927
Open AccessAsymmetric Dimethylarginine as an Integrative Biomarker of Endothelial, Cardiometabolic and Hepatic Dysfunction in Stable Coronary Artery Disease
Background: Coronary artery disease (CAD) frequently coexists with cardiometabolic and hepatic dysfunction, yet accessible biomarkers capturing this convergence remain limited. Asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, has been proposed as an integrative marker of endothelial and metabolic impairment. This study aimed to evaluate the diagnostic value of ADMA as a unified biomarker of endothelial dysfunction (ED), cardiometabolic burden, and metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with stable CAD. Methods: In this cross-sectional study, 298 patients with stable CAD (functional class I–II) were enrolled at two centers in Tashkent, Uzbekistan. Serum ADMA was measured by ELISA; endothelial function was assessed by flow-mediated dilation (FMD). Associations between ADMA, metabolic indices, MASLD, and CAD severity were analyzed. Results: MASLD was present in 48.3% of CAD patients and metabolic syndrome (MetS) in 62.4%. Patients with MASLD had more severe angina, reduced exercise tolerance, and greater ischemic burden than those without. ADMA correlated positively with BMI, waist circumference, TyG index, and TG/HDL-C ratio (all p < 0.001), with the TyG index showing the strongest predictive value for elevated ADMA (AUC 0.76). A dose–response relationship linked rising ADMA to worsening FMD; concentrations >160 ng/mL conferred markedly increased odds of overt ED (OR 114.8, 95% CI 6.8–1935.0) and were disproportionately prevalent in patients with MASLD (93.1% vs. 61.0%, p < 0.001). Conclusions: ADMA is markedly elevated in stable CAD and closely tracks endothelial, metabolic, and hepatic dysfunction. These cross-sectional associations position ADMA as a promising, hypothesis-generating integrative biomarker; prospective longitudinal studies are needed before its use for risk stratification in primary and cardiovascular care can be recommended.
- Open Access
- 9 July 2026
- Published by MDPI AG in Preprints.org
Genetic Polymorphism of the FGB G-455A Gene in Patients with Ischemic Heart Disease of Uzbek Nationality
This study aimed to examine the distribution of allele and genotype frequencies of the β-fibrinogen -455G/A polymorphism among patients with ischemic heart disease (IHD) and to evaluate fibrinogen levels according to genotype. Materials and methods: A total of 135 patients with primarily stable angina pectoris were included, comprising 57 men and 78 women, hospitalised in the First Cardiology Department of the Multidisciplinary Clinic at Tashkent Medical University. The mean age was 58.0 ± 1.2 years (range: 42–66 years). The control group consisted of 40 apparently healthy individuals. Results: In the main group, genotype frequencies were G/G – 53.3%, G/A – 22.2%, and A/A – 24.4%. In the control group, the respective frequencies were 57.5%, 22.5%, and 20.0%. The lowest fibrinogen levels were found in G/G genotype carriers, while the highest were observed in A/A genotype carriers. Conclusion: Although allele frequencies were similar between groups, a marked genotype-dependent effect on fibrinogen levels was identified. These findings align with published evidence that the A allele is associated with increased fibrinogen synthesis and a more prothrombotic phenotype.
- 9 July 2026
- Published by MDPI AG in Preprints.org
Open AccessGenetic Polymorphism of the FGB G-455A Gene in Patients with Ischemic Heart Disease of Uzbek Nationality
This study aimed to examine the distribution of allele and genotype frequencies of the β-fibrinogen -455G/A polymorphism among patients with ischemic heart disease (IHD) and to evaluate fibrinogen levels according to genotype. Materials and methods: A total of 135 patients with primarily stable angina pectoris were included, comprising 57 men and 78 women, hospitalised in the First Cardiology Department of the Multidisciplinary Clinic at Tashkent Medical University. The mean age was 58.0 ± 1.2 years (range: 42–66 years). The control group consisted of 40 apparently healthy individuals. Results: In the main group, genotype frequencies were G/G – 53.3%, G/A – 22.2%, and A/A – 24.4%. In the control group, the respective frequencies were 57.5%, 22.5%, and 20.0%. The lowest fibrinogen levels were found in G/G genotype carriers, while the highest were observed in A/A genotype carriers. Conclusion: Although allele frequencies were similar between groups, a marked genotype-dependent effect on fibrinogen levels was identified. These findings align with published evidence that the A allele is associated with increased fibrinogen synthesis and a more prothrombotic phenotype.
- Open Access
- 1 July 2026
- Published by MDPI AG in Preprints.org
An Integrated Model of Cardiotoxicity: Interaction of Age, Sex, and Genetic Factors in the Development of Structural and Functional Myocardial Abnormalities
Cardiotoxic complications are influenced by demographic and genetic factors that contribute to myocardial structural and electrophysiological abnormalities. This study aimed to assess the impact of age, sex, and genetic polymorphisms on the development of cardiotoxic complications. A total of 89 patients aged 18–78 years underwent electrocardiography, echocardiography, and molecular genetic testing for polymorphisms in GPX4, SOD2, COL1A1, CAT, EDN1, and COMT. Left ventricular hypertrophy (LVH) was detected in 58.4% of patients, reduced left ventricular ejection fraction (LVEF <50%) in 23.6%, arrhythmias in 46.1%, and ischemic changes in 28.1%. Increasing age was associated with LVH, reduced LVEF, and ischemic myocardial changes (p<0.05). Sex-specific differences showed a higher prevalence of rhythm disturbances in women and ischemic changes in men. Individual genetic polymorphisms were associated with specific cardiac phenotypes, while combined genetic risk (≥2 unfavourable alleles) was significantly associated with higher rates of LVH, arrhythmias, and impaired myocardial contractility. The findings support a polygenic model of cardiotoxicity and highlight the relevance of integrating demographic and genetic factors to enable personalised cardiovascular risk stratification and early prevention of cardiac complications.
- 1 July 2026
- Published by MDPI AG in Preprints.org
Open AccessAn Integrated Model of Cardiotoxicity: Interaction of Age, Sex, and Genetic Factors in the Development of Structural and Functional Myocardial Abnormalities
Cardiotoxic complications are influenced by demographic and genetic factors that contribute to myocardial structural and electrophysiological abnormalities. This study aimed to assess the impact of age, sex, and genetic polymorphisms on the development of cardiotoxic complications. A total of 89 patients aged 18–78 years underwent electrocardiography, echocardiography, and molecular genetic testing for polymorphisms in GPX4, SOD2, COL1A1, CAT, EDN1, and COMT. Left ventricular hypertrophy (LVH) was detected in 58.4% of patients, reduced left ventricular ejection fraction (LVEF <50%) in 23.6%, arrhythmias in 46.1%, and ischemic changes in 28.1%. Increasing age was associated with LVH, reduced LVEF, and ischemic myocardial changes (p<0.05). Sex-specific differences showed a higher prevalence of rhythm disturbances in women and ischemic changes in men. Individual genetic polymorphisms were associated with specific cardiac phenotypes, while combined genetic risk (≥2 unfavourable alleles) was significantly associated with higher rates of LVH, arrhythmias, and impaired myocardial contractility. The findings support a polygenic model of cardiotoxicity and highlight the relevance of integrating demographic and genetic factors to enable personalised cardiovascular risk stratification and early prevention of cardiac complications.
- Open Access
- 29 June 2026
- Published by Republican Specialized Scientific-Practical Medical Center of Cardiology in CARDIOLOGY OF UZBEKISTAN
- Vol. 3 (2) , 73-84
The PRMT–ADMA–DDAH Axis in Cardiovascular Disease: Linking Protein Arginine Methylation to Endothelial Dysfunction and Vascular Remodeling.
Endothelial dysfunction is a central pathophysiological process underlying the initiation and progression of cardiovascular disease and is characterized by impaired nitric oxide (NO) bioavailability, increased oxidative stress, inflammation, vasoconstriction, and prothrombotic vascular signaling. Among the endogenous regulators of the NO pathway, asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, has emerged as an important molecular link between metabolic stress and vascular dysfunction. However, circulating ADMA represents only one component of a broader regulatory network involving protein arginine methyltransferases (PRMTs), dimethylarginine dimethylaminohydrolases (DDAHs), and alternative methylarginine-metabolizing pathways. This review examines the molecular architecture of the PRMT–ADMA–DDAH–eNOS/NO axis and its contribution to atherosclerosis, coronary artery disease, hypertension, heart failure, cardiometabolic disorders, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease. Finally, we discuss the therapeutic potential and limitations of targeting PRMT activity, ADMA metabolism, DDAH1, AGXT2, and NO bioavailability. Understanding this regulatory network may provide a mechanistic framework for identifying endothelial phenotypes of residual cardiovascular risk and developing more individualized strategies for cardiovascular prevention and treatment.
- 29 June 2026
- Published by Republican Specialized Scientific-Practical Medical Center of Cardiology in CARDIOLOGY OF UZBEKISTAN
- Vol. 3 (2) , 73-84
Open AccessThe PRMT–ADMA–DDAH Axis in Cardiovascular Disease: Linking Protein Arginine Methylation to Endothelial Dysfunction and Vascular Remodeling.
Endothelial dysfunction is a central pathophysiological process underlying the initiation and progression of cardiovascular disease and is characterized by impaired nitric oxide (NO) bioavailability, increased oxidative stress, inflammation, vasoconstriction, and prothrombotic vascular signaling. Among the endogenous regulators of the NO pathway, asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, has emerged as an important molecular link between metabolic stress and vascular dysfunction. However, circulating ADMA represents only one component of a broader regulatory network involving protein arginine methyltransferases (PRMTs), dimethylarginine dimethylaminohydrolases (DDAHs), and alternative methylarginine-metabolizing pathways. This review examines the molecular architecture of the PRMT–ADMA–DDAH–eNOS/NO axis and its contribution to atherosclerosis, coronary artery disease, hypertension, heart failure, cardiometabolic disorders, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease. Finally, we discuss the therapeutic potential and limitations of targeting PRMT activity, ADMA metabolism, DDAH1, AGXT2, and NO bioavailability. Understanding this regulatory network may provide a mechanistic framework for identifying endothelial phenotypes of residual cardiovascular risk and developing more individualized strategies for cardiovascular prevention and treatment.
- Open Access
- 8 January 2026
- Published by Zotarelli-Filho Scientific Works in International Journal of Nutrology
- Vol. 19 (1)
Randomized controlled trial of omega-3 fatty acid supplementation and probiotic therapy on insulin sensitivity in obesity-related metabolic syndrome
The metabolic syndrome of obesity has well-defined habitat-related mechanisms associated with obesity, insulin resistance, dyslipidemia, and inflammation, which collectively serve as habit-challenging and problematic issues related to obesity and obesity-related metabolic syndrome. Clearly, nutritional approaches signify the most important types of non-pharmacological treatment that can be explored and are extremely relevant. Two approaches of specific interest, perhaps because they have overlapping yet complementary mechanisms, are omega-3 fatty acids and probiotics. The current nutrologic study assessed the effect of Omega-3 fatty acid vs probiotic treatment on insulin sensitivity in an obese population with metabolic syndrome. Omega-3 fatty acids have many systemic effects (i.e., EPA and DHA), specifically with respect to the metabolic processing of the lipid component of an underlying disordered metabolic state, reducing pro-inflammatory cytokines, and improving insulin signalling at the cellular level. Alternatively, probiotics may come from a different basis and also work via a gut–metabolic axis, through the modulation of gut microbiota, re-establishing the functional gut barrier, and increasing short-chain fatty acids, which may affect glucose metabolism. The clinical examination of the results showed that both dietary strategies influenced different indices of insulin sensitivity, whereas Omega-3 fatty acids influenced lipids, and probiotics tended to be more representative of the modulation of gut-related pathways by the varied dietary strategies. So the effects are synthetically presented here, i.e., in summary, mainly because of the comparisons made, but the differences were examined in several contexts in order to demonstrate the complementary dietary gradients in the two interventions. In conclusion, flexibility for both therapies may be realized with a consideration for their combined use under personalized nutrology protocols to generate better metabolic outcomes. This nutrological viewpoint respects the same perceptions of dietary strategies being very nuanced with modifications to address the burden of metabolic syndrome and supports longer duration studies or trials with prolonged exposure to treatment, considering therapies in different populations, as well as exploring possibilities of dose response or synergistic treatment in metering changes.
- 8 January 2026
- Published by Zotarelli-Filho Scientific Works in International Journal of Nutrology
- Vol. 19 (1)
Open AccessRandomized controlled trial of omega-3 fatty acid supplementation and probiotic therapy on insulin sensitivity in obesity-related metabolic syndrome
The metabolic syndrome of obesity has well-defined habitat-related mechanisms associated with obesity, insulin resistance, dyslipidemia, and inflammation, which collectively serve as habit-challenging and problematic issues related to obesity and obesity-related metabolic syndrome. Clearly, nutritional approaches signify the most important types of non-pharmacological treatment that can be explored and are extremely relevant. Two approaches of specific interest, perhaps because they have overlapping yet complementary mechanisms, are omega-3 fatty acids and probiotics. The current nutrologic study assessed the effect of Omega-3 fatty acid vs probiotic treatment on insulin sensitivity in an obese population with metabolic syndrome. Omega-3 fatty acids have many systemic effects (i.e., EPA and DHA), specifically with respect to the metabolic processing of the lipid component of an underlying disordered metabolic state, reducing pro-inflammatory cytokines, and improving insulin signalling at the cellular level. Alternatively, probiotics may come from a different basis and also work via a gut–metabolic axis, through the modulation of gut microbiota, re-establishing the functional gut barrier, and increasing short-chain fatty acids, which may affect glucose metabolism. The clinical examination of the results showed that both dietary strategies influenced different indices of insulin sensitivity, whereas Omega-3 fatty acids influenced lipids, and probiotics tended to be more representative of the modulation of gut-related pathways by the varied dietary strategies. So the effects are synthetically presented here, i.e., in summary, mainly because of the comparisons made, but the differences were examined in several contexts in order to demonstrate the complementary dietary gradients in the two interventions. In conclusion, flexibility for both therapies may be realized with a consideration for their combined use under personalized nutrology protocols to generate better metabolic outcomes. This nutrological viewpoint respects the same perceptions of dietary strategies being very nuanced with modifications to address the burden of metabolic syndrome and supports longer duration studies or trials with prolonged exposure to treatment, considering therapies in different populations, as well as exploring possibilities of dose response or synergistic treatment in metering changes.
- Open Access
- 10 November 2025
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 10 (4) , 283-289
Role of the plasma level of plasminogen activator inhibitor type-1 (PAI-1) and genetic polymorphism of PAI-1 gene in patients with ischemic heart disease in Uzbek population
Aim – to study the distribution of allele frequencies of the polymorphic marker 4G(-675)5G of the PAI-1 gene among patients with coronary heart disease and individuals with risk factors for the development of coronary heart disease. Material and methods. The study included 63 patients with diagnosed coronary heart disease, especially with stable angina (48 men and 15 women) hospitalized in the 1st Cardiology Department of the Multidisciplinary Clinic of the Tashkent Medical Academy. The average age of patients was 56.8 ± 6.40 years (42-66 years old). The state of hypercoagulability was assessed by measures of polymorphism gene of PAI-1 and plasma level of PAI-1. Results. The assessment of the frequency of various variants of the 4G(-675)5G polymorphic marker of the PAI-1 gene showed that differences in the distribution of the 5G/5G, 4G/5G, 4G/4G genotypes depending on the functional class of coronary artery disease are not statistically significant, since the chi-square test value was χ2 = 1.85 (p 0.05). Based on the obtained results, it can be assumed that the presence of hetero- and homozygous variants of the 4G allele of the PAI-1 gene does not affect the severity of the disease, in particular, the functional class of stable angina. Conclusion. The 4G/5G polymorphism of the PAI-1 gene was significantly associated with the risk of coronary heart disease in the Uzbek population. When stratified by angina functional class, the results showed that the 4G/5G polymorphism is associated with an increased risk of coronary heart disease and higher plasma PAI-1 levels.
- 10 November 2025
- Published by FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation in Science and Innovations in Medicine
- Vol. 10 (4) , 283-289
Open AccessRole of the plasma level of plasminogen activator inhibitor type-1 (PAI-1) and genetic polymorphism of PAI-1 gene in patients with ischemic heart disease in Uzbek population
Aim – to study the distribution of allele frequencies of the polymorphic marker 4G(-675)5G of the PAI-1 gene among patients with coronary heart disease and individuals with risk factors for the development of coronary heart disease. Material and methods. The study included 63 patients with diagnosed coronary heart disease, especially with stable angina (48 men and 15 women) hospitalized in the 1st Cardiology Department of the Multidisciplinary Clinic of the Tashkent Medical Academy. The average age of patients was 56.8 ± 6.40 years (42-66 years old). The state of hypercoagulability was assessed by measures of polymorphism gene of PAI-1 and plasma level of PAI-1. Results. The assessment of the frequency of various variants of the 4G(-675)5G polymorphic marker of the PAI-1 gene showed that differences in the distribution of the 5G/5G, 4G/5G, 4G/4G genotypes depending on the functional class of coronary artery disease are not statistically significant, since the chi-square test value was χ2 = 1.85 (p 0.05). Based on the obtained results, it can be assumed that the presence of hetero- and homozygous variants of the 4G allele of the PAI-1 gene does not affect the severity of the disease, in particular, the functional class of stable angina. Conclusion. The 4G/5G polymorphism of the PAI-1 gene was significantly associated with the risk of coronary heart disease in the Uzbek population. When stratified by angina functional class, the results showed that the 4G/5G polymorphism is associated with an increased risk of coronary heart disease and higher plasma PAI-1 levels.
- 30 October 2025
- Published by National Institute of STEM Research in International Journal of Aquatic Research and Environmental Studies
- Vol. 5 (2) , 328-337
Role of aquatic ecosystem engineers in modulating sediment dynamics and nutrient cycling
This study aims to design the aquatic environments (aquatic organisms that bring physical changes), which influence the organization and the operations of aquatic environments in a considerable way. Other processes, implying that the engineers are macroinvertebrates and macrophytes in mediating the processes of sediment and nutrient delivery in the diverse aquatic ecosystems (freshwater, estuarine, and marine), are also addressed in the study as an essential complex process. We generalize the literature on the path to developing a comprehensive scheme of how the engineers, e.g., bioturbators and reef-builders, modify the properties of sediments, e.g., grain size, presence of water, and redox conditions that lead to the regulation of the biogeochemical processes. Its main objective is to define the ecological effects of the different types of engineers in transporting the primary nutrients, especially nitrogen (N) and phosphorus (P), which are vital to the productivity of the water, but also cause eutrophication. These are our primary inputs: we have described a new conceptual model, which connects specific engineering processes (e.g., burrowing, filtering) with quantifiable variations in the stability of the sediment and changes in the stoichiometry of nutrient emission at the sediment-water interface. We give the context-dependency of these effects a scan in terms of what characteristics of the surrounding environment, such as flow regimes and the nature of the surrounding sediment, might mediate the impact of engineers. In addition to this, we highlight the fact that there must be an opportunity for the utilization of ecological services under such organisms in the future restoration of the aquatic ecosystem and a management plan to enhance the quality of water and environmental stability. This synthesis determines the invaluable importance of aquatic ecosystem engineers as a source of biogeochemical heterogeneity and process to the waters of the world, which gives future empirical investigations and conservation programs a solid foundation.
- 30 October 2025
- Published by National Institute of STEM Research in International Journal of Aquatic Research and Environmental Studies
- Vol. 5 (2) , 328-337
Role of aquatic ecosystem engineers in modulating sediment dynamics and nutrient cycling
This study aims to design the aquatic environments (aquatic organisms that bring physical changes), which influence the organization and the operations of aquatic environments in a considerable way. Other processes, implying that the engineers are macroinvertebrates and macrophytes in mediating the processes of sediment and nutrient delivery in the diverse aquatic ecosystems (freshwater, estuarine, and marine), are also addressed in the study as an essential complex process. We generalize the literature on the path to developing a comprehensive scheme of how the engineers, e.g., bioturbators and reef-builders, modify the properties of sediments, e.g., grain size, presence of water, and redox conditions that lead to the regulation of the biogeochemical processes. Its main objective is to define the ecological effects of the different types of engineers in transporting the primary nutrients, especially nitrogen (N) and phosphorus (P), which are vital to the productivity of the water, but also cause eutrophication. These are our primary inputs: we have described a new conceptual model, which connects specific engineering processes (e.g., burrowing, filtering) with quantifiable variations in the stability of the sediment and changes in the stoichiometry of nutrient emission at the sediment-water interface. We give the context-dependency of these effects a scan in terms of what characteristics of the surrounding environment, such as flow regimes and the nature of the surrounding sediment, might mediate the impact of engineers. In addition to this, we highlight the fact that there must be an opportunity for the utilization of ecological services under such organisms in the future restoration of the aquatic ecosystem and a management plan to enhance the quality of water and environmental stability. This synthesis determines the invaluable importance of aquatic ecosystem engineers as a source of biogeochemical heterogeneity and process to the waters of the world, which gives future empirical investigations and conservation programs a solid foundation.
- 30 October 2025
- Published by National Institute of STEM Research in International Journal of Aquatic Research and Environmental Studies
- Vol. 5 (2) , 440-448
Deep-Sea ecosystems and their role in biogeochemical cycles and carbon sequestration
Deep-sea ecosystems have transitioned from being perceived as biological deserts and geochemically inactive to being recognized as major players in regulating Earth's biogeochemical cycles and long-term carbon storage. They include various ocean-floor environments, such as abyssal plains, hydrothermal vents, cold seeps, seamounts, and hadal trenches, each with its own microbial and faunal communities that promote nutrient cycling and organic matter decomposition. The process of deep-ocean carbon storage is multistep. It includes the sinking of particulate organic carbon from surface waters, microbial carbon fixation, and burial of the organic material in sediments over geological timescales. Recent research has shown that deep-sea inhabitants are actively involved in nutrient remineralization, methane oxidation, and the stabilization of carbon-rich compounds, thereby influencing global climate dynamics. Nevertheless, the security of these processes is put at risk by trawling, mining, plastic pollution, and changes in ocean chemistry associated with warming. As human activities push into deeper oceans, gaining a thorough understanding of biological interactions, sediment processes, and carbon fluxes is essential. This review compiles existing knowledge of deep-sea ecosystem services, identifies uncertainties in carbon budget calculations, and suggests the need for improved monitoring using autonomous observation systems and high-resolution modeling. The preservation of deep-sea areas is hence a key factor not only for supporting biodiversity but also for maintaining their crucial role in regulating Earth's climate.
- 30 October 2025
- Published by National Institute of STEM Research in International Journal of Aquatic Research and Environmental Studies
- Vol. 5 (2) , 440-448
Deep-Sea ecosystems and their role in biogeochemical cycles and carbon sequestration
Deep-sea ecosystems have transitioned from being perceived as biological deserts and geochemically inactive to being recognized as major players in regulating Earth's biogeochemical cycles and long-term carbon storage. They include various ocean-floor environments, such as abyssal plains, hydrothermal vents, cold seeps, seamounts, and hadal trenches, each with its own microbial and faunal communities that promote nutrient cycling and organic matter decomposition. The process of deep-ocean carbon storage is multistep. It includes the sinking of particulate organic carbon from surface waters, microbial carbon fixation, and burial of the organic material in sediments over geological timescales. Recent research has shown that deep-sea inhabitants are actively involved in nutrient remineralization, methane oxidation, and the stabilization of carbon-rich compounds, thereby influencing global climate dynamics. Nevertheless, the security of these processes is put at risk by trawling, mining, plastic pollution, and changes in ocean chemistry associated with warming. As human activities push into deeper oceans, gaining a thorough understanding of biological interactions, sediment processes, and carbon fluxes is essential. This review compiles existing knowledge of deep-sea ecosystem services, identifies uncertainties in carbon budget calculations, and suggests the need for improved monitoring using autonomous observation systems and high-resolution modeling. The preservation of deep-sea areas is hence a key factor not only for supporting biodiversity but also for maintaining their crucial role in regulating Earth's climate.